Bionano Genomics Inc. (BNGO) Fundamentals

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
SHARE INFORMATION
Market Cap$ 668,080,125
Shares Outstanding296,924,500
Float296,749,486
Percent Float99.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 17,981,000
Latest Fiscal EPS$ -0.26
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions300
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months10,179,253
Institutional Holdings Percent47.3%
Institutional Sold Previous 3 Months11,817,185
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months20,000
Insider Holdings Percent2.0
Insider Sold Previous 3 Months40,000
Insider Shares Owned5,944,272
TRADING INFO
52 Week High$ 4.41
52 Week Low$ 1.16
52 Week High Change$ -45.52
21 Day Moving Average$ 2.3914
21 Day Extended Moving Average$ 2.3672
50 Day Moving Average$ 2.189
50 Day Extended Moving Average$ 2.2884
200 Day Moving Average$ 2.049
200 Day Extended Moving Average$ 2.4422
10 Day Average Volume8,507,173
20 Day Average Volume7,861,792
30 Day Average Volume7,843,556
50 Day Average Volume6,963,885
Alpha0.086331
Beta2.2606
Standard Deviation0.874528
R20.021957
7 Day Price Change$ -0.44
7 Day Percent Change-16.36%
21 Day Price Change$ 0.02
21 Day Percent Change0.9%
30 Day Price Change$ 0.11
30 Day Percent Change5.14%
Month to Date Price Change$ -0.09
Month to Date Percent Change-3.85%
Quarter to Date Price Change$ 0.42
Quarter to Date Percent Change22.95%
180 Day Price Change$ 0.68
180 Day Percent Change43.31%
200 Day Price Change$ 0.69
200 Day Percent Change44.23%
Year to Date Price Change$ -0.74
Year to Date Percent Change-24.75%

Bionano Genomics Inc. (BNGO) Key Ratios

PROFITABILITY
EBIT Margin-472.3%
EBITDA Margin-437.9%
Pre-Tax Profit Margin-324.3%
Profit Margin Count0.0%
Gross Margin16.9%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 25,889,000
Revenue Per Share$ 0.0872
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.30
Total Debt To Equity0.00
Int Coverage-441.40
Current Ratio6.50
Leverage Ratio1.10
Quick Ratio5.60
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio-5.40
Enterprise Value$ 489,374,390
Price to Sales25.8056
Price to Free Cash-3.90
PE High Last 5 Years0.00
Price To Book2.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.00
Invoice Turnover1.30
Assets Turnover0.10
Return Assets-37.20
Return on Equity-40.93
Return on Capital-36.45

Bionano Genomics Inc. (BNGO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOR. Erik Holmlin
Emplyoees299
Last AuditUE
CIK0001411690
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing(334510)
CONTACT INFO
Address9540 Towne Centre Drive
Suite 100
San Diego, CA 92121
Websitehttps://www.bionanogenomics.com
Facsimile+1 858 888-7601
Telephone+1 858 888-7600
Emaileholmlin@bionanogenomics.com


Your Recent History
NASDAQ
BNGO
Bionano Ge..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.